Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis. Bone Marrow Transplant 2001;28:265-70. http://dx.doi.org/10.1038/sj.bmt.1703129 PMid:11535994...
Suppressive Therapy: The recommended dosage of valacyclovir tablets for chronic suppressive therapy of recurrent genital herpes is 1 gram once daily in patients with normal immune function. In patients with a history of 9 or fewer recurrences per year, an alternative dose is 500 mg once daily. In...
Formulation Product development team includes experienced Scientists who continuously work for the development of New Drug Product, Dietary Supplement, Generic Drug Products, Novel Drugs Delivery System (NDDS), New fixed dose combination products and Herbal Cosmetics & Herbal Products. ...
It can also be used for prevention of herpesvirus infection in immunocompromised patients. Ganciclovir is indicated for the treatment of cytomegalovirus ... MR Keating - 《Mayo Clinic Proceedings Mayo Clinic》 被引量: 143发表: 1999年 Pre-transplant ganciclovir and post transplant high-dose valacyclov...
Prophylaxis (for up to 1 year) Immunocompetent (<9 episodes/year): 500 mg orally daily Immunocompetent (9 or more per year): 1000 mg orally daily HIV with CD4>100: 500 mg orally twice dailyChicken Pox (immunocompetent) Age 2 to 12 years: 20 mg/kg/dose (max 1000 mg) orally three...
Valacyclovir for the pre- vention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis. Bone Marrow Transplant 2001; 28:265-270.Vusirikala M, Wolff SN, Stein RS, et al. Valaciclovir for the prevention of cytomegalovirus infection ...
Methods: A total of 208 CMV-negative recipients of a kidney from a seropositive donor and 408 CMV-positive recipients were randomly assigned to receive either 2 g of valacyclovir or placebo orally four times daily for 90 days after transplantation, with the dose adjusted according to renal ...
Renal toxicity of high‐dosage valacyclovir for secondary prevention of congenital cytomegalovirus infection: a dose regimen‐related issuedoi:10.1002/uog.24753Y. VilleUniversité de Paris And Institut IMAGINE,Paris,France↑Fetal Medicine and Surgery and Fetal Imaging, H?pital Necker Enfants‐Malades,...
Prevention of cytomegalovirus (CMV) reactivation by standard dose valacyclovir (VACV) after allogeneic bone marrow transplantationcalcificationosteoclastatherosclerosishyperlipidemiaosteoporosisObjectives-Osteoporosis is associated epidemiologically with atherosclerosis and hyperlipidemia. We previously found that atherogenic ...
an intensified prevention strategy was adopted at the FHCRC (Seattle, WA) which consists of pre-transplant ganciclovir (from day -8 to day -2), and high-dose acyclovir ([HDA] 2 gm valacyclovir 3 times daily) with preemptive bi-weekly monitoring for CMV DNA in serum from day 0 until da...